Health system executive brings three decades of medical enterprise experience to Labcorp
BURLINGTON, N.C., June 7, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointment of Dr. Paul Rothman to its Board of Directors as an independent member. Dr. Rothman's appointment is effective June 6, 2023, at which time the Board will expand to 12 directors, 11 of whom are independent.
Read more at prnewswire.com